Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. 2011

Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
Department of Diagnostic Imaging, Rhode Island Hospital, 593 Eddy St., Providence, RI 02903, USA. mbeland@lifespan.org

OBJECTIVE The objective of our study was to evaluate the accuracy of dynamic contrast-enhanced 4D MDCT in the preoperative identification of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT) and a history of failed surgery or unsuccessful localization on standard imaging. METHODS Thirty-four patients with PHPT underwent 4D CT. Retrospective blinded review of the 4D CT examinations was performed by three radiologists for the presence and location of a suspected parathyroid adenoma or adenomas. At the time of the study, 25 patients underwent surgical exploration after 4D CT. Twenty patients had solitary parathyroid adenomas, two patients had two adenomas resected, two patients did not have an adenoma, and one patient had mild four-gland hyperplasia. One patient did not have PHPT on repeat serum biochemistry. Surgical and pathology reports, adenoma enhancement, and biochemical and clinical follow-up were reviewed. Data were compared with 4D CT interpretations and interobserver reliability was calculated. RESULTS The mean sensitivity and specificity of the three readers for the precise CT localization of adenomas was 82% (range, 79-88%) and 92% (range, 75-100%), respectively. Overall interobserver reliability was excellent (κ = 0.70; range, κ = 0.60-0.79). All adenomas resected at surgery showed a biochemical response and clinical response. The mean densities of the confirmed adenomas were 41, 128, 138, and 109 HU at 0, 30, 60, and 90 seconds, respectively. Level II lymph nodes identified in 10 patients showed significantly less enhancement at 30 (p = 0.0001) and 60 (p = 0.006) seconds compared with surgically proven adenomas. CONCLUSIONS Occult parathyroid adenoma shows characteristic early enhancement. In this subset of patients, 4D CT may improve surgical outcomes and decrease morbidity.

UI MeSH Term Description Entries
D007472 Iohexol An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Compound 545,Exypaque,Iohexol 350,Nycodenz,Omnipaque
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010282 Parathyroid Neoplasms Tumors or cancer of the PARATHYROID GLANDS. Cancer of Parathyroid,Parathyroid Cancer,Cancer of the Parathyroid,Neoplasms, Parathyroid,Parathyroid Adenoma,Parathyroid Carcinoma,Adenoma, Parathyroid,Adenomas, Parathyroid,Cancer, Parathyroid,Cancers, Parathyroid,Carcinoma, Parathyroid,Carcinomas, Parathyroid,Neoplasm, Parathyroid,Parathyroid Adenomas,Parathyroid Cancers,Parathyroid Carcinomas,Parathyroid Neoplasm
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
July 1973, Der Urologe. Ausg. A,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
July 2019, EJNMMI research,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
December 1994, Surgery,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
July 1984, Deutsche medizinische Wochenschrift (1946),
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
February 2017, Clinical nuclear medicine,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
December 2015, AJNR. American journal of neuroradiology,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
November 2021, Problemy endokrinologii,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
June 2003, Talanta,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
February 1992, Minerva chirurgica,
Michael D Beland, and William W Mayo-Smith, and David J Grand, and Jason T Machan, and Jack M Monchik
October 2014, Clinical endocrinology,
Copied contents to your clipboard!